Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML

NCT06635681 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

AML (Acute Myelogenous Leukemia)

Interventions

DRUG: Daunorubicin
DRUG: Cytarabine
DRUG: Venetoclax
DRUG: Azacitidine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China